Lifecore Biomedical Inc.

LFCR | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.47

-$0.01 (-0.22%)

Sep 22, 2026, 11:48 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.22%

(1D)

Rating

Updated: Sep 11, 2026

31.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $167.67M

1D Range

4.37 4.52

52W Range

3.63 8.98

Valuation (TTM)

PE -4.07

PB 10.44

EV/EBITDA -73.90

Valuation (NTM)

Forward PE N/A

Forward PEG 0.32

Price Target $6.50

Cash Flow

FCF Yield -1.1%

SBC Adj. FCF Yield -6.0%

SBC Impact -459.6%

Margins

Gross Margin 29.7%

Operating Margin -2.1%

FCF Margin -1.5%

Growth (CAGR)

Revenue 3Y | 5Y 7.9% | -22.9%

Dil EPS 3Y | 5Y -92.6% | 36.3%

FCF 3Y | 5Y 73.0% | 49.8%

Returns

ROA -16.3%

ROE -376.9%

ROIC -1.3%

Financial Health

Net Debt

$137.83M

Current Ratio 3.87

Interest Coverage -0.09

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Nether...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 382

IPO Date Feb 14, 1996

Website www.lifecore.com

Fiscal Year June - May

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 3, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$6.50

Upside

+45.41%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞